FDA Advises Against Antifungal Drug's Use In Studies
The U.S. Food and Drug Administration advised drugmakers on Wednesday not to use Johnson & Johnson's antifungal treatment Nizoral or similar oral medications in drug interaction studies, saying the risk of...To view the full article, register now.
Already a subscriber? Click here to view full article